Most Profitable Pharmaceuticals Companies

Net Income
Net IncomeEfficiencyMarket RiskExp Return
1TAK Takeda Pharmaceutical Co
144.07 B
 0.20 
 1.16 
 0.23 
2NVO Novo Nordisk AS
100.99 B
(0.09)
 2.85 
(0.25)
3RDY Dr Reddys Laboratories
55.68 B
(0.15)
 1.56 
(0.23)
4MRK Merck Company
17.13 B
(0.10)
 1.82 
(0.18)
5JNJ Johnson Johnson
14.07 B
 0.16 
 1.15 
 0.19 
6NVS Novartis AG ADR
11.94 B
 0.20 
 1.35 
 0.27 
7LLY Eli Lilly and
10.59 B
 0.07 
 2.02 
 0.14 
8AZN AstraZeneca PLC ADR
8.69 B
 0.16 
 1.17 
 0.19 
9PFE Pfizer Inc
8.05 B
(0.03)
 1.18 
(0.03)
10SNY Sanofi ADR
5.5 B
 0.17 
 1.36 
 0.23 
11GSK GlaxoSmithKline PLC ADR
2.95 B
 0.14 
 1.74 
 0.25 
12ZTS Zoetis Inc
2.5 B
(0.01)
 1.65 
(0.02)
13RPRX Royalty Pharma Plc
1.33 B
 0.27 
 1.85 
 0.50 
14OGN Organon Co
864 M
 0.02 
 2.79 
 0.04 
15JAZZ Jazz Pharmaceuticals PLC
560.12 M
 0.08 
 1.70 
 0.13 
16ELAN Elanco Animal Health
338 M
(0.10)
 2.13 
(0.21)
17PBH Prestige Brand Holdings
209.34 M
 0.06 
 2.38 
 0.14 
18AMPH Amphastar P
159.52 M
(0.20)
 2.33 
(0.46)
19HRMY Harmony Biosciences Holdings
145.49 M
 0.00 
 3.02 
 0.00 
20CORT Corcept Therapeutics Incorporated
141.21 M
 0.06 
 3.57 
 0.21 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors. Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.